New insider Lialios Christopher claimed ownership of 2,918 shares (SEC Form 3)
$ULTA
Other Specialty Stores
Consumer Discretionary
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 06/27/2025 |
3. Issuer Name and Ticker or Trading Symbol
Ulta Beauty, Inc. [ ULTA ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 2,918(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (right to buy) | (2) | 03/29/2029 | Common Stock | 266 | $348.73 | D | |
| Stock Option (right to buy) | (3) | 03/27/2030 | Common Stock | 1,138 | $174.45 | D | |
| Stock Option (right to buy) | (4) | 03/25/2031 | Common Stock | 354 | $306.59 | D | |
| Stock Option (right to buy) | (5) | 03/24/2032 | Common Stock | 350 | $395.84 | D | |
| Stock Option (right to buy) | (6) | 03/25/2033 | Common Stock | 273 | $545.67 | D | |
| Stock Option (right to buy) | (7) | 03/24/2034 | Common Stock | 359 | $522.88 | D | |
| Stock Option (right to buy) | (8) | 03/24/2035 | Common Stock | 812 | $366.54 | D | |
| Explanation of Responses: |
| 1. Includes shares underlying restricted stock units of which 185 shares settle on March 15, 2026; 198 shares settle on March 15, 2027; and 558 shares settle on March 15, 2028. |
| 2. The options, representing an initial right to purchase a total of 1,062 shares, vesting in 25% annual increments beginning March 15, 2020 and each anniversary thereafter through March 15, 2023. |
| 3. The options, representing an initial right to purchase a total of 2,275 shares, vesting in 25% annual increments beginning March 15, 2021 and each anniversary thereafter through March 15, 2024. |
| 4. The options, representing an initial right to purchase a total of 471 shares, vesting in 25% annual increments beginning March 15, 2022 and each anniversary thereafter through March 15, 2025. |
| 5. The options, representing an initial right to purchase a total of 350 shares, vesting in 25% annual increments beginning March 15, 2023 and each anniversary thereafter through March 15, 2026. |
| 6. The options, representing an initial right to purchase a total of 273 shares, vesting in 25% annual increments beginning March 15, 2024 and each anniversary thereafter through March 15, 2027. |
| 7. The options, representing an initial right to purchase a total of 359 shares, vesting in 25% annual increments beginning March 15, 2025 and each anniversary thereafter through March 15, 2028. |
| 8. The options, representing an initial right to purchase a total of 812 shares, vesting in 25% annual increments beginning March 15, 2026 and each anniversary thereafter through March 15, 2029. |
| /s/ Rene G. Casares, as attorney-in-fact for Christopher Lialios | 07/07/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||